Eyestem is a cell therapy firm established by a proficient management team comprising experts in clinical trials, cell therapy, and ophthalmology. With a distinguished advisory board and strategic collaborations with industry pioneers, they aim to develop a scalable cell therapy platform. Their overarching goal is to address incurable diseases and make advanced technologies accessible to the global population's majority, thereby democratizing healthcare.